ananta medicare
ENDLESS CARE ABOUT YOUR HEALTH
#
India
News of World Medicine

Research Highlights Importance of Genetic Testing and Novel Biomarkers in Cystic Fibrosis Diagnosis and Monitoring

VIENNA — Advances in genetic testing and newly discovered biomarkers can help screen newborns and monitor inflammation and pulmonary exacerbations in patients diagnosed with cystic fibrosis.

At the European Respiratory Society (ERS) 2024 International Congress, clinical researchers presented results from the Turkish context.

Cystic fibrosis is the most common genetic disorder among Caucasians. The average prevalence at birth in Europe is 1 in 5000, whereas the overall population averages 1 in 9000. Both rates vary significantly based on geographic area. In the central Anatolia region, one study found that the incidence of cystic fibrosis is 1 in 3400 live births.

 

Source: MEDspace